With the annual increase in diabetes prevalence, the number of diabetic patients is projected to reach 1.31 billion by 2050 [4], imposing a heavy burden on both patients and healthcare systems
When a molecule of active GSH encounters a free radical and donates its electron to neutralize the threat, it becomes oxidized
The system not only avoids dysglycemia but also effectively reduces weight to alter symptoms, significantly improves metabolic disorders associated with diabetes, and reduces the risk of diabetic complications
Not by grand pronouncements or miracle cures, but by small molecules doing precise work at the cellular level
(2022b, October 7)
By directly scavenging reactive oxygen species (ROS), it helps to prevent mitochondrial dysfunction, supports ATP synthesis, and inhibits the pathways leading to cell death, including apoptosis